Effect of Ketamine on Analgesia Post-Cardiac Surgery
CompletedPhase 4NCT02925858
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
Randomized, controlled, double-blind pilot study evaluating the effect of an intraoperative infusion of intravenous Ketamine on the quantity of opioid consumed postoperatively in coronary artery bypass surgery patients receiving a median sternotomy.
Study details
- Official title
- Pilot Study: The Effect of Intraoperative Ketamine on Analgesia Post-Cardiac Surgery and Prevention of Chronic Pain
- Conditions
- Interventions
- Drug: Normal Saline Flush, 0.9% Injectable Solution_#1
- Drug: Ketamine Hydrochloride
- Sponsor
- Jewish General Hospital
- Start date
- 2017-08-28
- Primary completion
- 2018-11-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients 18 years of age or older coming for coronary artery bypass surgery with a left ventricular ejection fraction over 50% and able to consent prior to surgery Exclusion Criteria: * Minimally invasive cardiac surgery * Preoperative opioid use * Preoperative hepatic or renal dysfunction
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02925858